Gonadotropin-Releasing Hormone (GnRH)-Antagonist Versus GnRH-Agonist in Ovarian Stimulation of Poor Responders Undergoing IVF
Authors:
- 1 November 2003
- journal article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 20 (11) , 455-460
Abstract
Purpose : The objective of this study was to compare the efficacy of GnRH-antagonists to GnRH-agonists in ovarian stimulation of poor responders undergoing IVF. Methods : Retrospective analysis of our data revealed that 56 patients underwent treatment with a GnRH-agonist according to the flare-up protocol. Patients failing to achieve an ongoing pregnancy (n=53) were subsequently treated in the next cycle with a GnRH-antagonist according to the multiple-dose protocol. Main outcome measures included the clinical pregnancy and implantation rates. Results : While ovulation induction characteristics and results did not differ between the two protocols, the number of embryos transferred was significantly higher (P=0.046) in the GnRH-antagonist than in the GnRH-agonist stimulation protocol (2.5 ± 1.6 vs. 2.0 ± 1.4, respectively). The clinical pregnancy and implantation rates per transfer in the GnRH-antagonist group appeared higher than in the GnRH-agonist, but did not differ statistically (26.1 and 10.7 compared with 12.2 and 5.9%, respectively). However, the ongoing pregnancy rate per transfer was statistically significantly higher (P=0.03) in the GnRH-antagonist than in the GnRH-agonist group (23.9 vs. 7.3%, respectively). Conclusion : Applying GnRH-antagonists to ovarian stimulation protocols may offer new hope for IVF poor responder patients. However, further controlled randomized prospective studies with larger sample sizes are required to establish these results.Keywords
This publication has 20 references indexed in Scilit:
- Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trialHuman Reproduction, 2001
- Will GnRH antagonists provide new hope for patients considered `difficult responders' to GnRH agonist protocols?Human Reproduction, 1999
- Cessation of Gonadotropin-Releasing Hormone Agonist Therapy Combined with High-Dose Gonadotropin Stimulation Yields Favorable Pregnancy Results in Low RespondersFertility and Sterility, 1998
- Clinical and Endocrine Effects of a Microdose GnRH Agonist Flare Regimen Administered to Poor Responders Who Are Undergoing In Vitro FertilizationFertility and Sterility, 1998
- Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocolFertility and Sterility, 1997
- Intracytoplasmic sperm injection: a powerful tool to overcome fertilization failureFertility and Sterility, 1996
- Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levelsFertility and Sterility, 1994
- Treatment of low respondersJournal of Assisted Reproduction and Genetics, 1993
- Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levelsFertility and Sterility, 1991
- Outcome of in vitro fertilization in women with low response to ovarian stimulationFertility and Sterility, 1987